Stroke, Vol 25, 1666-1673, Copyright © 1994 by American Heart Association
S Blot, JF Arnal, Y Xu, F Gray and JB Michel
BACKGROUND AND PURPOSE: Chronic hypertension is a major predisposing factor
for stroke in humans. It has recently been shown that long-term inhibition
of nitric oxide synthase activity causes a gradual time- dependent increase
in arterial blood pressure in rats. We used this new animal model of
chronic hypertension to study the occurrence and spatial features of
infarcts in the central nervous system. METHODS: Rats were treated with a
nitric oxide synthase inhibitor, NG-nitro-L- arginine methyl ester,
dissolved in the drinking water at 50 mg/kg per day for 11 weeks. The
brains and spinal cords of hypertensive rats with and without motion
disturbances were processed for standard microscopic examination. RESULTS:
Seventy-nine percent of the hypertensive rats showed motion dysfunctions,
especially front leg paralysis, and/or died suddenly when their systolic
blood pressure reached approximately 215 mm Hg after approximately 7 weeks
of treatment. All of the hypertensive rats with stroke had spinal cord
infarcts (90% at the cervical or cervicothoracic level) either alone or
combined with brain lesions (30%). These structural alterations ranged from
focal areas of pale, spongy tissue to large necrotic sites with vascular
alterations, including thickened or fibrinoid degenerated vessel wall,
macrophage invasion, and reactive astrocytes. CONCLUSIONS: Infarcts
occurred in the central nervous system with a high incidence in the spinal
cord of hypertensive rats in which nitric oxide synthase was chronically
blocked. This location of the hypertensive neuropathologic sequelae
contrasts with the model of stroke-prone spontaneously hypertensive rats.
The results suggest that nitric oxide is a key factor in spinal cord
arteriolar vasomotion and structure in rats.
ARTICLES
Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats
Ecole Veterinaire d'Alfort, Maisons-Alfort, France.
This article has been cited by other articles:
![]() |
M. Dupuis, F. Soubrier, I. Brocheriou, S. Raoux, M. Haloui, L. Louedec, J.-B. Michel, and S. Nadaud Profiling of Aortic Smooth Muscle Cell Gene Expression in Response to Chronic Inhibition of Nitric Oxide Synthase in Rats Circulation, August 17, 2004; 110(7): 867 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kataoka, K. Egashira, M. Ishibashi, S. Inoue, W. Ni, K.-i. Hiasa, S. Kitamoto, M. Usui, and A. Takeshita Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H768 - H774. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Enseleit, T.F. Luscher, and F. Ruschitzka Angiotensin-converting enzyme inhibition and endothelial dysfunction: focus on ramipril Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A31 - A36. [Abstract] [PDF] |
||||
![]() |
D. M. Attia, A. M. G. Verhagen, E. S. G. Stroes, E. E. van Faassen, H.-J. Grone, S. J. De Kimpe, H. A. Koomans, B. Braam, and J. A. Joles Vitamin E Alleviates Renal Injury, but Not Hypertension, during Chronic Nitric Oxide Synthase Inhibition in Rats J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2585 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, Y. Iida, H. Wakamatsu, K. Ohtake, K. Nakakimura, L. Xiong, and T. Sakabe The Effects of NG-Nitro-L-Arginine-Methyl Ester on Neurologic and Histopathologic Outcome After Transient Spinal Cord Ischemia in Rabbits Anesth. Analg., September 1, 1999; 89(3): 696 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nicoletti and J.-B. Michel Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors Cardiovasc Res, March 1, 1999; 41(3): 532 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zatz and C. Baylis Chronic Nitric Oxide Inhibition Model Six Years On Hypertension, December 1, 1998; 32(6): 958 - 964. [Full Text] [PDF] |
||||
![]() |
G. Luvara, M. E. Pueyo, M. Philippe, C. Mandet, F. Savoie, D. Henrion, and J.-B. Michel Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial Wall : Prevention by Angiotensin II Antagonism Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1408 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomita, K. Egashira, M. Kubo-Inoue, M. Usui, M. Koyanagi, H. Shimokawa, M. Takeya, T. Yoshimura, and A. Takeshita Inhibition of NO Synthesis Induces Inflammatory Changes and Monocyte Chemoattractant Protein-1 Expression in Rat Hearts and Vessels Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1456 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dohi, M. Kojima, and K. Sato Benidipine Improves Endothelial Function in Renal Resistance Arteries of Hypertensive Rats Hypertension, July 1, 1996; 28(1): 58 - 63. [Abstract] [Full Text] |
||||
![]() |
C. F. Kung, P. Moreau, H. Takase, and T. F. Luscher L-NAME Hypertension Alters Endothelial and Smooth Muscle Function in Rat Aorta : Prevention by Trandolapril and Verapamil Hypertension, November 1, 1995; 26(5): 744 - 751. [Abstract] [Full Text] |
||||
![]() |
P. Moreau, H. Takase, C. F. Kung, M.-M. van Rooijen, T. Schaffner, and T. F. Luscher Structure and Function of the Rat Basilar Artery During Chronic Nitric Oxide Synthase Inhibition Stroke, October 1, 1995; 26(10): 1922 - 1929. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |